Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $9.30, but opened at $8.65. Veradigm shares last traded at $9.49, with a volume of 29,002 shares.
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Veradigm in a research report on Tuesday. They set a “hold” rating for the company. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Veradigm has a consensus rating of “Hold” and a consensus price target of $12.00.
View Our Latest Analysis on MDRX
Veradigm Trading Up 2.0 %
Institutional Trading of Veradigm
A number of hedge funds and other institutional investors have recently modified their holdings of MDRX. Goldman Sachs Group Inc. grew its holdings in shares of Veradigm by 6.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after purchasing an additional 99,528 shares during the period. Vanguard Group Inc. increased its holdings in shares of Veradigm by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after buying an additional 95,291 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Veradigm by 117.8% during the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock valued at $60,908,000 after buying an additional 3,140,483 shares during the period. Forest Hill Capital LLC acquired a new position in Veradigm in the fourth quarter valued at approximately $210,000. Finally, Innealta Capital LLC purchased a new position in Veradigm in the second quarter worth approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- How to Buy Cheap Stocks Step by Step
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Why Invest in High-Yield Dividend Stocks?
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What are earnings reports?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.